Brief: Clinuvel Pharmaceuticals To Start 12-Mnth On-Market Share Buy-Back Program Of 1.5 Mln Ordinary Shares
14/03/2024 01:00
March 14 (Reuters) - Clinuvel Pharmaceuticals Ltd
CUV.AX :
* TO COMMENCE 12 MNTH ON-MARKET SHARE BUY-BACK PROGRAM OF UP
TO
1.5 MILLION ORDINARY SHARES
Further company coverage: CUV.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clinuvel Pharmaceuticals
See all newsBrief: Clinuvel Pharmaceuticals Announces Strategic Reorganisation To Refocus On U.S. Markets
Brief: Clinuvel Pharmaceuticals Ltd's ADS To Commence Trading On Nasdaq
Brief: Clinuvel Pharmaceuticals Says Scenesse Approved For EPP In Canada
Australia's Clinuvel Pharmaceuticals rises on Canada nod for phototoxicity prevention drug
Brief: Clinuvel Pharmaceuticals Updates On Level II ADR Upgrade, Nasdaq Uplist